Latest
Advisory Intelligence: ‘Deals and data’ are heartbeat of biotech
Sponsored content For companies in the biotech sector, 2021 is off to a fast start as capital-raising among new issuers crossed $6...
Advisory Intelligence: IROs see remit grow during tumultuous year
Sponsored content Amid the tumultuous events of 2020, the remit and influence of IR teams expanded considerably, according to new...
Advisory intelligence: Nasdaq’s ConnectIR sees use surge as investor relations goes virtual
Sponsored content This year several IR trends – from changes on the sell side as a result of Mifid II to greater competition for...
Advisory intelligence: Investors feeling more empowered to make longer-term decisions
Sponsored content Following second quarter results, investors now have improved visibility on the impact of Covid-19 and are...
Advisory intelligence: Social issues expected to dominate ESG discussions
Sponsored content Almost half of issuers (45 percent) expect social issues to be more of a focus in upcoming investor engagements...
Advisory intelligence: Why investors sold large-cap technology stocks
Sponsored content During the first quarter of 2020, as the reality of the Covid-19 pandemic dawned on investors, outflows in the...
Advisory intelligence: Evaluating your investor-facing ESG story
Sponsored content The rise of ESG investing strategies has been well documented, but the continued performance and demand for ESG...
Advisory intelligence: Nasdaq tracks investor inflows and outflows during Covid-19
Sponsored content The analysis paints a picture of how investors reacted to the spread of Covid-19, which caused stock markets to...
Advisory intelligence: Investor preferences toward capital allocation
Sponsored content While the 2010s witnessed a boom in shareholder buybacks, investor preferences have shifted in recent years to...
